Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion.

ABSTRACT:

SUBMITTER: Decool G 

PROVIDER: S-EPMC6746024 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature